Maine Medicine Weekly Update - 12/23/2020  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Maine’s COVID Vaccine Rollout Ramping Up; With Little Detail
•  The MMA Wishes Happy Holidays for All
•  Congress Passes New COVID Relief Bill
•  AMA Releases Revised 2021 E&M Codes
•  Governor Mills Extends Civil Emergency to 2021
•  Maine DHHS Launches Text Notifications to People Testing Positive for COVID-19
•  BinaxNOW DHHS Guidance Update
•  Maine CDC COVID-19 Vaccine Emergency Use Authorization (EUA) Fact Sheets/VIS Form
•  News of an Emerging Variant of COVID-19
•  Maine Physicians In The Media
•  Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
•  PPE Available Through the MMA & ActionPPE
•  Maine Medical Association Enduring Education Opportunity
•  MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions
•  Hanley's PELI Advanced Course Enrollment is OPEN!
•  A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
•  State Legislative Committees Announced
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  Webinar: “Radon Risk Reduction: The Current Policy Landscape in the US and the Maine Perspective” January 12, 2021
•  Maine Concussion Management Level 1 & 2 Training Via Zoom - January 15, 2021
•  Caring for LGBTQ+ Youth in Maine - Emphasis on the 'T' - Half-day Symposium on Saturday, January 23
•  MOA VIRTUAL Midwinter Symposium - Feb 12-14, 2021
•  Maine CDC Annual Prevention Professionals Conference - March 2-3, 2021
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Behavioral Health Clinician
•  Psychiatric Nurse Practitioner
•  Physician (BC/BE in Family Medicine)

 

News of an Emerging Variant of COVID-19

According the a US CDC scientific brief, “A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England.

 

According the a US CDC scientific brief, “A new variant strain of SARS-CoV-2 that contains a series of mutations has been described in the United Kingdom (UK) and become highly prevalent in London and southeast England. Based on these mutations, this variant strain has been predicted to potentially be more rapidly transmissible than other circulating strains of SARS-CoV-2. Although a variant may predominate in a geographic area, that fact alone does not mean that the variant is more infectious.”